Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

taj pharma Budesonide

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Budesonide Manufacturers in India Suppliers Budesonide Exporters Distributors Budesonide api active pharmaceuticals ingredients Budesonide manufacturers Side Effects bulk drugs raw material Budesonide companies Side Effects Importers Budesonide  Budesonide  Exporters Budesonide exporters FDA Budesonide DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Budesonide manufacturing pharmaceutical drugs pharmaceutical intermediates Budesonide pharmaceutical chemicals pharmaceutical raw materials Budesonide active pharmaceutical ingredients Budesonide committee active pharmaceutical ingredients manufacturer Budesonide Active Pharmaceutical Ingredients manufacturer Budesonide exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Budesonide, Budesonide manufacturer India, Budesonide product, Budesonide products, Api preparation, Certificate of Analysis API manufacturer product, Budesonide anti ulcer product, Certificate of Origin COA Budesonide  COS Budesonide, pharmaceutical generic, pharmaceutical drug, medical, Budesonide pharma healthcare, pharma patents, contract MSDS manufacturing Trader Budesonide pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Budesonide expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Budesonide DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Budesonide ingredients, api, HIV Budesonide, tablets, capsules, syrup & protein Budesonide powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Budesonide gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Budesonide WHO, UKMHRA Approval

   PRODUCT LIST
  Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 




 



































 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HOME >> API >> API List1 >> Budesonide


Budesonide CAS number 51333-22-3


CAS number 51333-22-3 pdf api

ATC code A07EA06 D07AC09, R01AD05, R03BA02

structural formula is:

Budesonide  CAS number 51333-22-3 Formula C25H34O6

Formula C25H34O6
Mol. mass 430.534 g/mol
SMILES eMolecules & PubChem


Its partition coefficient between octanol and water at pH 5 is 1.6 x 10.3

Pharmacokinetic data

Bioavailability 100% (but large first pass effect)
Protein binding 85-90%
Metabolism Hepatic CYP3A4
Half life 2.0-3.6 hours
Excretion Renal, Faecal

Chemical data

Budesonide is designated chemically as
(RS)-11-beta, 16-alpha, 17, 21-tetrahydroxypregna-1,
4-diene-3,20-dione cyclic 16, 17-acetal with butyraldehyde.

Budesonide is provided as the mixture of two epimers (22R and 22S).

The empirical formula of budesonide is C25H34O6 and its molecular weight is 430.5.

Budesonide is a white to off-white, odorless powder that is practically insoluble in water and in heptane,
sparingly soluble in ethanol, and freely soluble in chloroform.

GENERIC NAME: Budesonide

DRUG CLASS AND MECHANISM: Budesonide is a man-made glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone which is produced in the adrenal glands. It is used for treating asthma by inhalation. Glucocorticoid steroids such as cortisol or budesonide have potent anti-inflammatory actions that reduces inflammation and hyper-reactivity (spasm) of the airways caused by asthma. When used as an inhaler, the budesonide goes directly to the inner lining of the inflamed airways to exert its effects. Only 39% of an inhaled dose of budesonide is absorbed into the body, and the absorbed budesonide contributes little to the effects on the airways.

GENERIC AVAILABLE: No
PRESCRIPTION: Yes


PREPARATIONS:

Pulmicort Turbuhaler 200 mcg: each 200 mcg actuation delivers 160 mcg of budesonide.
Pulmicort Respules, 0.25 mg/2ml, 0.5 mg/2ml suspension, and 1 mg/2ml

STORAGE: Budesonide should be stored at room temperature, 20-25 C (68-77 F).

PRESCRIBED FOR: The budesonide inhaler is used for the control of asthma in persons requiring continuous, prolonged treatment. Such patients may include those with frequent asthmatic episodes requiring bronchodilators, for example, albuterol (Ventolin) or those with asthmatic episodes at night.

DOSING: Budesonide is used to prevent asthmatic attacks and should not be used to treat an acute attack of asthma. The Turbuhaler is used for individuals six years of age or older. Effects can be seen within 24 hours, but maximum effects may not be seen for 1-2 weeks or longer. Doses vary widely. Adults usually receive 1 to 4 actuations (puffs) twice daily. Children usually receive 1 to 2 puffs twice daily. For those with mild asthma, treatment once daily may be sufficient.

Pulmicort Respules are used for individuals 12 months to eight years of age. Effects are seen in 2 to 8 days, but maximum effects may not be seen for up to 4 to 6 weeks. Pulmicort Respules are used with a jet nebulizer. They usually are taken as one or two doses for a total of 0.5-1 mg daily.

DRUG INTERACTIONS: Ketoconazole (Nizoral, Extina, Xolegel, Kuric) increases the concentrations in blood of budesonide, and this may lead to an increase in the side effects of budesonide. No drug interactions have been described with inhaled budesonide.

PREGNANCY: When given orally to animals, glucocorticoid steroids similar to budesonide have been shown to cause fetal abnormalities. Studies of pregnant women using inhaled budesonide during early pregnancy, however, do not show an increase in the rate of fetal abnormalities. Nevertheless, since these studies cannot exclude the possibility of rare effects on the fetus, inhaled budesonide should be used with caution during pregnancy.

NURSING MOTHERS: It is not known if budesonide is secreted in breast milk. Other medications similar to budesonide are indeed secreted in breast milk. It is not known whether the small amounts that may appear in breast milk have effects on the infant.

SIDE EFFECTS: The most commonly noted side effects associated with inhaled budesonide are mild cough or wheezing; these effects may be minimized by using a bronchodilator inhaler, for example, albuterol (Ventolin), prior to the budesonide. Oral candidiasis or thrush (a fungal infection of the throat) may occur in 1 in 25 persons who use budesonide without a spacer device on the inhaler. The risk is even higher with large doses but is less in children than in adults. Hoarseness or sore throat also may occur in 1 in 10 persons. Using a spacer device on the inhaler and washing one's mouth out with water following each use reduces the risk of both thrush and hoarseness. Less commonly, alterations in voice may occur.

High doses of inhaled glucocorticoid steroids may decrease the formation and increase the breakdown of bone leading to weakened bones and ultimately osteoporosis and fractures. High doses may suppress the body's ability to make its own natural glucocorticoid in the adrenal gland. It is possible that these effects are shared by budesonide. People with suppression of their adrenal glands (which can be tested for by the doctor) need increased amounts of glucocorticoid steroids orally or intravenously during periods of high physical stress, for example, during infections, to prevent serious illness and shock.

Hypersensitivity reactions such as anaphylaxis, rash, contact dermatitis, itching, angioedema, and bronchospasm have been reported with use of inhaled budesonide. Use should be discontinued if such reactions occur.

Information Associated with Product:
DRUG DESCRIPTION
USES
DOSAGE
SIDE EFFECTS
PRECAUTIONS
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

 

Budesonide

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.